Literature DB >> 18716168

Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.

Davide Grassi1, Giovambattista Desideri, Stefano Necozione, Cristina Lippi, Raffaele Casale, Giuliana Properzi, Jeffrey B Blumberg, Claudio Ferri.   

Abstract

Flavanols from chocolate appear to increase nitric oxide bioavailability, protect vascular endothelium, and decrease cardiovascular disease (CVD) risk factors. We sought to test the effect of flavanol-rich dark chocolate (FRDC) on endothelial function, insulin sensitivity, beta-cell function, and blood pressure (BP) in hypertensive patients with impaired glucose tolerance (IGT). After a run-in phase, 19 hypertensives with IGT (11 males, 8 females; 44.8 +/- 8.0 y) were randomized to receive isocalorically either FRDC or flavanol-free white chocolate (FFWC) at 100 g/d for 15 d. After a wash-out period, patients were switched to the other treatment. Clinical and 24-h ambulatory BP was determined by sphygmometry and oscillometry, respectively, flow-mediated dilation (FMD), oral glucose tolerance test, serum cholesterol and C-reactive protein, and plasma homocysteine were evaluated after each treatment phase. FRDC but not FFWC ingestion decreased insulin resistance (homeostasis model assessment of insulin resistance; P < 0.0001) and increased insulin sensitivity (quantitative insulin sensitivity check index, insulin sensitivity index (ISI), ISI(0); P < 0.05) and beta-cell function (corrected insulin response CIR(120); P = 0.035). Systolic (S) and diastolic (D) BP decreased (P < 0.0001) after FRDC (SBP, -3.82 +/- 2.40 mm Hg; DBP, -3.92 +/- 1.98 mm Hg; 24-h SBP, -4.52 +/- 3.94 mm Hg; 24-h DBP, -4.17 +/- 3.29 mm Hg) but not after FFWC. Further, FRDC increased FMD (P < 0.0001) and decreased total cholesterol (-6.5%; P < 0.0001), and LDL cholesterol (-7.5%; P < 0.0001). Changes in insulin sensitivity (Delta ISI - Delta FMD: r = 0.510, P = 0.001; Delta QUICKI - Delta FMD: r = 0.502, P = 0.001) and beta-cell function (Delta CIR(120) - Delta FMD: r = 0.400, P = 0.012) were directly correlated with increases in FMD and inversely correlated with decreases in BP (Delta ISI - Delta 24-h SBP: r = -0.368, P = 0.022; Delta ISI - Delta 24-h DBP r = -0.384, P = 0.017). Thus, FRDC ameliorated insulin sensitivity and beta-cell function, decreased BP, and increased FMD in IGT hypertensive patients. These findings suggest flavanol-rich, low-energy cocoa food products may have a positive impact on CVD risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716168     DOI: 10.1093/jn/138.9.1671

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  112 in total

1.  Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats.

Authors:  Andrew P Neilson; Teryn N Sapper; Elsa M Janle; Ralf Rudolph; Nathan V Matusheski; Mario G Ferruzzi
Journal:  J Agric Food Chem       Date:  2010-06-09       Impact factor: 5.279

2.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

3.  Intake of cocoa products and risk of type-2 diabetes: the multiethnic cohort.

Authors:  Gertraud Maskarinec; Simone Jacobs; Yurii Shvetsov; Carol J Boushey; Veronica W Setiawan; Laurence N Kolonel; Christopher A Haiman; Loïc Le Marchand
Journal:  Eur J Clin Nutr       Date:  2018-05-24       Impact factor: 4.016

Review 4.  Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Authors:  Arrigo F G Cicero; Alessandro Colletti
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-19

5.  (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity.

Authors:  Maik Hüttemann; Icksoo Lee; Guy A Perkins; Steven L Britton; Lauren G Koch; Moh H Malek
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

Review 6.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

7.  Does chocolate reduce blood pressure? A meta-analysis.

Authors:  Karin Ried; Thomas Sullivan; Peter Fakler; Oliver R Frank; Nigel P Stocks
Journal:  BMC Med       Date:  2010-06-28       Impact factor: 8.775

8.  Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.

Authors:  Tiffany F Hughes; Mary Ganguli
Journal:  Curr Psychiatry Rev       Date:  2009-05-01

9.  Dark chocolate or tomato extract for prehypertension: a randomised controlled trial.

Authors:  Karin Ried; Oliver R Frank; Nigel P Stocks
Journal:  BMC Complement Altern Med       Date:  2009-07-08       Impact factor: 3.659

Review 10.  Polyphenols from cocoa and vascular health-a critical review.

Authors:  Gerald Rimbach; Mona Melchin; Jennifer Moehring; Anika E Wagner
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.